Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Cooper

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
American Heart Journal|July 11, 2006
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trialChristopher J Cooper, Timothy P Murphy, Alan Matsumoto, et al.
Kidney International|August 25, 2022
Hemopexin accumulates in kidneys and worsens acute kidney injury by causing hemoglobin deposition and exacerbation of iron toxicity in proximal tubulesXiaoming Fan, Xiaolu Zhang, Lijun C Liu, et al.
Journal of the American College of Cardiology|December 15, 2015
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure GradientTimothy P Murphy, Christopher J Cooper, Alan H Matsumoto, et al.
Physiological Genomics|December 25, 2015
Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblastsChristopher A Drummond, Michael C Hill, Huilin Shi, et al.
Vascular Medicine (London, England)|August 2, 2014
Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidatesNicholas J Hendricks, Alan H Matsumoto, John F Angle, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 12, 2013
Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) studyTimothy P Murphy, Christopher J Cooper, Donald E Cutlip, et al.
Scientific Reports|August 13, 2017
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney DiseaseJeffrey X Xie, Helen Alderson, James Ritchie, et al.
JAMA|November 6, 2003
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trialSteven E Nissen, Taro Tsunoda, E Murat Tuzcu, et al.
Physiological Genomics|October 30, 2016
Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosisChristopher A Drummond, Laura E Crotty Alexander, Steven T Haller, et al.
Journal of the American Heart Association|October 4, 2016
Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic SignalingSteven T Haller, Yanling Yan, Christopher A Drummond, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
American Heart Journal|July 11, 2006
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trialChristopher J Cooper, Timothy P Murphy, Alan Matsumoto, et al.
Kidney International|August 25, 2022
Hemopexin accumulates in kidneys and worsens acute kidney injury by causing hemoglobin deposition and exacerbation of iron toxicity in proximal tubulesXiaoming Fan, Xiaolu Zhang, Lijun C Liu, et al.
Journal of the American College of Cardiology|December 15, 2015
Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure GradientTimothy P Murphy, Christopher J Cooper, Alan H Matsumoto, et al.
Physiological Genomics|December 25, 2015
Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblastsChristopher A Drummond, Michael C Hill, Huilin Shi, et al.
Vascular Medicine (London, England)|August 2, 2014
Is fibromuscular dysplasia underdiagnosed? A comparison of the prevalence of FMD seen in CORAL trial participants versus a single institution population of renal donor candidatesNicholas J Hendricks, Alan H Matsumoto, John F Angle, et al.
Journal of Vascular and Interventional Radiology : JVIR|December 12, 2013
Roll-in experience from the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) studyTimothy P Murphy, Christopher J Cooper, Donald E Cutlip, et al.
Scientific Reports|August 13, 2017
Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney DiseaseJeffrey X Xie, Helen Alderson, James Ritchie, et al.
JAMA|November 6, 2003
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trialSteven E Nissen, Taro Tsunoda, E Murat Tuzcu, et al.
Physiological Genomics|October 30, 2016
Cigarette smoking causes epigenetic changes associated with cardiorenal fibrosisChristopher A Drummond, Laura E Crotty Alexander, Steven T Haller, et al.
Journal of the American Heart Association|October 4, 2016
Rapamycin Attenuates Cardiac Fibrosis in Experimental Uremic Cardiomyopathy by Reducing Marinobufagenin Levels and Inhibiting Downstream Pro-Fibrotic SignalingSteven T Haller, Yanling Yan, Christopher A Drummond, et al.
Pageof 9